López OY; López MC; Corredor V; Echeverry MC; Pinilla AE.:
2012.[Differentiation of entamoeba histolytica from entamoeba dispar using Gal/GalNAc-lectin and polymerase chain reaction]. Rev Med Chil. 140(4):476- 83.(In Spanish)
Obado SO; Bot C; Echeverry MC; Bayona JC; Alvarez VE; Taylor MC; Kelly
JM.:
2011.Centromere-associated topoisomerase activity in bloodstream form
Trypanosoma brucei. Nucleic Acids Res. 39(3):1023-33.
Marcela Parra-Muñoz; Samanda Aponte; Clemencia Ovalle-Bracho; Carlos H. Saavedra; and María C. Echeverry.:
Detection of Leishmania RNA Virus in Clinical Samples from Cutaneous Leishmaniasis Patients Varies according to the Type of Sample. The American journal of tropical medicine and hygiene, 2021, vol. 104, no 1, p. 233.
Téllez J; Echeverry MC; Romero I; Guatibonza A; Santos Ramos G; Borges De Oliveira AC; Frézard F; Demicheli C.:
Use of liposomal nanoformulations in antileishmania therapy: challenges and perspectives. Journal of Liposome Research, 2021, vol. 31, no 2, p. 169-176.
Laverde-Paz, M. J; Echeverry, M. C; Patarroyo, M. A; Bello, F. J.:
Evaluating the anti-leishmania activity of Lucilia sericata and Sarconesiopsis magellanica blowfly larval excretions/secretions in an in vitro model. Acta Trop. Jan;177:44- 50. doi:10.1016/j.actatropica.2017.09.033.
Perez-Franco JE; Cruz-Barrera ML; Robayo ML; Lopez MC; Daza CD;
Bedoya A; Mariño ML; Saavedra CH; Echeverry MC.:
2016. Clinical and parasitological features of patients with American Cutaneous Leishmaniasis that did not respond to treatment with meglumine antimoniate. PLoS Negl Trop
Dis.10(5):e0004739. doi: 10.1371/journal.pntd.0004739
Cruz-Barrera ML; Ovalle-Bracho C; Ortegon-Vergara V; Pérez-Franco JE;
Echeverry MC.:
2015. Improving Leishmania species identification in different
types of samples from cutaneous lesions. J Clin Microbiol. 53(4):1339-41
Echeverry MC; Bot C; Obado SO; Taylor MC; Kelly JM.:
2012. Centromereassociated
repeat arrays on Trypanosoma brucei chromosomes are much more
extensive than predicted. BMC Genomics.13(1):29.
Jones KT; Echeverry M; Mosser VA; Gates A; Jackson DA.:
2006. Agonist mediated internalization of M2 mAChR is beta-arrestin-dependent. J Mol Signal. 1:1-7.
Agudelo C; Corredor A; Echeverry MC; Salcedo H and B Murrain:
1995. [Malaria: Fundamentals and Scope of Control. Characteristics in Colombia]. Infectio1:31-55 (in Spanish)
Corredor, A; Echeverry MC; Salcedo H; Alvarado H and E Mendez.:
1993. [A human case of ¿Angystrongylus costarricensis¿from Mitu Colombia]. Biomédica. 12 supp1:87-88 (in Spanish)